51 related articles for article (PubMed ID: 9359522)
1. The production of tissue inhibitors of metalloproteinases (TIMPs) in megakaryopoiesis: possible role of platelet- and megakaryocyte-derived TIMPs in bone marrow fibrosis.
Murate T; Yamashita K; Isogai C; Suzuki H; Ichihara M; Hatano S; Nakahara Y; Kinoshita T; Nagasaka T; Yoshida S; Komatsu N; Miura Y; Hotta T; Fujimoto N; Saito H; Hayakawa T
Br J Haematol; 1997 Oct; 99(1):181-9. PubMed ID: 9359522
[TBL] [Abstract][Full Text] [Related]
2. Methodologic research on TIMP-1, TIMP-2 detection as a new diagnostic index for hepatic fibrosis and its significance.
Nie QH; Cheng YQ; Xie YM; Zhou YX; Bai XG; Cao YZ
World J Gastroenterol; 2002 Apr; 8(2):282-7. PubMed ID: 11925608
[TBL] [Abstract][Full Text] [Related]
3. Programmable 3D silk bone marrow niche for platelet generation ex vivo and modeling of megakaryopoiesis pathologies.
Di Buduo CA; Wray LS; Tozzi L; Malara A; Chen Y; Ghezzi CE; Smoot D; Sfara C; Antonelli A; Spedden E; Bruni G; Staii C; De Marco L; Magnani M; Kaplan DL; Balduini A
Blood; 2015 Apr; 125(14):2254-64. PubMed ID: 25575540
[TBL] [Abstract][Full Text] [Related]
4. The Analysis of the Human Megakaryocyte and Platelet Coding Transcriptome in Healthy and Diseased Subjects.
De Wispelaere K; Freson K
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886993
[TBL] [Abstract][Full Text] [Related]
5. Megakaryocyte-bone cell interactions: lessons from mouse models of experimental myelofibrosis and related disorders.
Stavnichuk M; Komarova SV
Am J Physiol Cell Physiol; 2022 Feb; 322(2):C177-C184. PubMed ID: 34910601
[TBL] [Abstract][Full Text] [Related]
6. Ultrastructural alterations of megakaryocytes in thrombocytopenia: A review of 43 cases.
Eyden B; Ru YX; Dong SX; Liu J; Liu XF
Blood Sci; 2021 Oct; 3(4):107-112. PubMed ID: 35402843
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 Lysate Stimulation Impairs the Release of Platelet-like Particles and Megakaryopoiesis in the MEG-01 Cell Line.
Lopardo V; Montella F; Esposito RM; Zannella C; Aliberti SM; Capunzo M; Franci G; Puca AA; Ciaglia E
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902151
[TBL] [Abstract][Full Text] [Related]
8. Fibrosis and bone marrow: understanding causation and pathobiology.
Ghosh K; Shome DK; Kulkarni B; Ghosh MK; Ghosh K
J Transl Med; 2023 Oct; 21(1):703. PubMed ID: 37814319
[TBL] [Abstract][Full Text] [Related]
9. The 'rejuvenating factor' TIMP-2 is detectable in human blood components for transfusion.
Hoefer J; Dal-Pont C; Jochberger S; Fantin R; Schennach H
Vox Sang; 2021 May; 116(5):533-539. PubMed ID: 33107073
[TBL] [Abstract][Full Text] [Related]
10. Hemodialysis exacerbates proteolytic imbalance and pro-fibrotic platelet dysfunction.
Velasquez-Mao AJ; Velasquez MA; Hui Z; Armas-Ayon D; Wang J; Vandsburger MH
Sci Rep; 2021 Jun; 11(1):11764. PubMed ID: 34083719
[TBL] [Abstract][Full Text] [Related]
11. Clinical impact of glycans in platelet and megakaryocyte biology.
Falet H; Rivadeneyra L; Hoffmeister KM
Blood; 2022 Jun; 139(22):3255-3263. PubMed ID: 35015813
[TBL] [Abstract][Full Text] [Related]
12. Platelets and osteoblasts: secretome connections.
Tiedemann K; Tsao S; Komarova SV
Am J Physiol Cell Physiol; 2022 Aug; 323(2):C347-C353. PubMed ID: 35675640
[TBL] [Abstract][Full Text] [Related]
13. A Novel Mechanism for Bone Loss: Platelet Count Negatively Correlates with Bone Mineral Density via Megakaryocyte-Derived RANKL.
Kikuchi S; Wada A; Kamihara Y; Yamamoto I; Kirigaya D; Kunimoto K; Horaguchi R; Fujihira T; Nabe Y; Minemura T; Dang NH; Sato T
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569526
[TBL] [Abstract][Full Text] [Related]
14. Megakaryocyte buds are distinct from microvesicles and likely to represent platelet precursors.
Ellis ML; Alwis I; Smythe R; Yuan Y; Jackson SP
Blood Adv; 2023 Mar; 7(6):982-986. PubMed ID: 36355836
[No Abstract] [Full Text] [Related]
15. Platelet lysates from aged donors promote human tenocyte proliferation and migration in a concentration-dependent manner.
Berger DR; Centeno CJ; Steinmetz NJ
Bone Joint Res; 2019 Jan; 8(1):32-40. PubMed ID: 30800297
[TBL] [Abstract][Full Text] [Related]
16. MMP-2, MMP-9, and TIMP-4 and Response to Aspirin in Diabetic and Nondiabetic Patients with Stable Coronary Artery Disease: A Pilot Study.
Kuliczkowski W; Radomski M; Gąsior M; Urbaniak J; Kaczmarski J; Mysiak A; Negrusz-Kawecka M; Bil-Lula I
Biomed Res Int; 2017; 2017():9352015. PubMed ID: 28770228
[TBL] [Abstract][Full Text] [Related]
17. Platelet glycoproteins associated with aspirin-treatment upon platelet activation.
Shah P; Yang W; Sun S; Pasay J; Faraday N; Zhang H
Proteomics; 2017 Mar; 17(6):. PubMed ID: 27452734
[TBL] [Abstract][Full Text] [Related]
18. Hematopoiesis in mice is extremely resilient to wide variation in TIMP/MMP balance.
Haviernik P; Diaz MT; Haviernikova E; Tse W; Stetler-Stevenson WG; Bunting KD
Blood Cells Mol Dis; 2008; 41(2):179-87. PubMed ID: 18487063
[TBL] [Abstract][Full Text] [Related]
19. Identification, regulation and role of tissue inhibitor of metalloproteinases-4 (TIMP-4) in human platelets.
Radomski A; Jurasz P; Sanders EJ; Overall CM; Bigg HF; Edwards DR; Radomski MW
Br J Pharmacol; 2002 Dec; 137(8):1330-8. PubMed ID: 12466243
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of intermittent and continuous administration of parathyroid hormone on bone histomorphometry and gene expression.
Lotinun S; Sibonga JD; Turner RT
Endocrine; 2002 Feb; 17(1):29-36. PubMed ID: 12014700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
